Overview

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
To compare palonosetron with granisetron hydrochloride as a control in the efficacy of intravenous single dose in preventing acute and delayed gastro-intestinal disorders, such as nausea and vomiting induced by highly emetogenic chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Taiho Pharmaceutical Co., Ltd.
Treatments:
Emetics
Granisetron
Palonosetron